A Cross-Sectional Post-Authorization Safety Study to Assess Healthcare Provider Awareness of Risks Associated with Zydelig® in the European Union

27/07/2017
16/02/2024
EU PAS number:
EUPAS16606
Study
Finalised
Documents
Study protocol
Initial protocol
English (789.38 KB - PDF) View document
Study results
Study results
English (349.57 KB - PDF) View document
Study report
Other information